Betty Ferrell1, Vincent Chung2, Marianna Koczywas2, Tami Borneman1, Terry L Irish3, Nora H Ruel4, Nilofer S Azad5, Rhonda S Cooper6, Thomas J Smith5. 1. Division of Nursing Research and Education, City of Hope National Medical Center, Duarte, California, USA. 2. Department of Oncology, City of Hope National Medical Center, Duarte, California, USA. 3. City of Hope National Medical Center, Duarte, California, USA. 4. Beckman Research Institute, City of Hope National Medical Center, Duarte, California, USA. 5. Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA. 6. Chaplain of the Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA.
Abstract
OBJECTIVES: Patients with cancer who are at a transition to Phase I investigational treatments have been identified as an underserved population with regard to palliative care. This disease transition is often accompanied by spiritual and existential concerns. The study objective was to conduct a secondary analysis of data from a larger study testing a palliative care intervention. This paper reports the findings of this secondary focus on the spiritual needs of this population. METHODS: Patients (n = 479) were accrued to this study prior to initiating a Phase I clinical trial with data collected at baseline, and 4, 12, and 24 week follow-up. RESULTS: Qualitative data revealed that the transition to Phase 1 trial participation is a time of balancing hope for extended life with the reality of advancing disease. Quantitative results demonstrated increased spirituality over time in both religious- and non-religious-affiliated patients. CONCLUSIONS: Patients entering Phase I trials have important spiritual needs as they face treatment decisions, advancing disease, and often mortality. Spiritual care should be provided to seriously ill patients as a component of quality care.
OBJECTIVES: Patients with cancer who are at a transition to Phase I investigational treatments have been identified as an underserved population with regard to palliative care. This disease transition is often accompanied by spiritual and existential concerns. The study objective was to conduct a secondary analysis of data from a larger study testing a palliative care intervention. This paper reports the findings of this secondary focus on the spiritual needs of this population. METHODS: Patients (n = 479) were accrued to this study prior to initiating a Phase I clinical trial with data collected at baseline, and 4, 12, and 24 week follow-up. RESULTS: Qualitative data revealed that the transition to Phase 1 trial participation is a time of balancing hope for extended life with the reality of advancing disease. Quantitative results demonstrated increased spirituality over time in both religious- and non-religious-affiliated patients. CONCLUSIONS: Patients entering Phase I trials have important spiritual needs as they face treatment decisions, advancing disease, and often mortality. Spiritual care should be provided to seriously ill patients as a component of quality care.
Authors: Stephen Duane King; George Fitchett; Patricia E Murphy; Kenneth I Pargament; Paul J Martin; Rebecca H Johnson; David A Harrison; Elizabeth Trice Loggers Journal: Psychooncology Date: 2015-11-15 Impact factor: 3.894
Authors: Tracy A Balboni; George Fitchett; George F Handzo; Kimberly S Johnson; Harold G Koenig; Kenneth I Pargament; Christina M Puchalski; Shane Sinclair; Elizabeth J Taylor; Karen E Steinhauser Journal: J Pain Symptom Manage Date: 2017-07-20 Impact factor: 3.612
Authors: Karen E Steinhauser; George Fitchett; George F Handzo; Kimberly S Johnson; Harold G Koenig; Kenneth I Pargament; Christina M Puchalski; Shane Sinclair; Elizabeth J Taylor; Tracy A Balboni Journal: J Pain Symptom Manage Date: 2017-07-18 Impact factor: 3.612
Authors: Stephen D W King; George Fitchett; Patricia E Murphy; Kenneth I Pargament; David A Harrison; Elizabeth Trice Loggers Journal: Support Care Cancer Date: 2016-10-06 Impact factor: 3.603
Authors: Lynn A Jansen; Daruka Mahadevan; Paul S Appelbaum; William M P Klein; Neil D Weinstein; Motomi Mori; Racky Daffé; Daniel P Sulmasy Journal: Cancer Date: 2016-02-16 Impact factor: 6.860
Authors: Patricia Gonzalez; Sheila F Castañeda; Jennifer Dale; Elizabeth A Medeiros; Christina Buelna; Alicia Nuñez; Rebeca Espinoza; Gregory A Talavera Journal: Support Care Cancer Date: 2014-04-02 Impact factor: 3.603